Temporal Arteritis

Giant Cell / Temporal Arteritis

1. Introduction

Giant cell arteritis also known as temporal arteritis is an inflammatory disease affecting the large blood vessels of the scalp, neck and arms. Inflammation causes a narrowing or blockage of the blood vessels, which interrupts blood flow. It is a serious condition and needs urgent treatment. (1)

The disease is commonly associated with polymyalgia rheumatica, a condition that causes pain, stiffness and inflammation in the muscles around the shoulders, neck and hips. As well as perceived muscle stiffness, other signs of polymyalgia rheumatica include extreme tiredness, loss of appetite, weight loss, and depression. (2)

Frequently Asked Questions

Giant cell arteritis, also known as Temporal Arteritis, is an inflammatory disease affecting the large blood vessels of the scalp, neck and arms. The most common symptom being a “headache like no other”.

Very rare – It affects less than 1% of the UK population each year. (1)

Yes. If you feel you have some of the symptoms associated with this condition, please seek medical advice urgently as a delay in treatment can lead to serious complications. It is a serious condition and needs urgent treatment.

Caucasian women over the age of 50. (3)

Most common between the ages of 70 and 80 years of age. (3)

Common symptoms may include: (2)

  • Regular, severe headaches.
  • Pain and tenderness over the temples.
  • Jaw pain while eating or talking.
  • Visual disturbance.
  • Flu-like symptoms.
  • Unintentional weight loss.
  • Depression.
  • Tiredness.

Seek immediate medical advice. Normally, this condition is treated effectively with steroid medication. Treatment will often be started straight away because of the risk of vision loss if it’s not dealt with quickly.

Symptoms are often reversible with a prolonged course of steroids; however, they can persist for 1-2 years or longer. (2)

We recommend consulting a musculoskeletal physiotherapist to ensure exercises are best suited to your recovery. If you are carrying out an exercise regime without consulting a healthcare professional, you do so at your own risk.

2. Signs and Symptoms

  • New-onset headache is the most common symptom usually in the temple region. (3)
  • Approximately 30% of people will have temporal artery abnormality presenting as tenderness, thickening, or lumpiness in the temple region. (3)
  • Up to 30% of people develop visual loss that may come or go, or be permanent, and could affect both eyes. (5)
  • Scalp tenderness particular over the temples and back of the head. (6)
  • Intermittent discomfort, weakness and tension of the jaw muscles. (7)
  • Other general features may include fever, fatigue, weight loss, and depression. (8)
  • Giant cell arteritis may develop with or after polymyalgia rheumatica, which occurs in about 40% to 50% of people with giant cell arteritis. (9)

3. Causes

The exact cause is unknown but is still being studied. It is thought to involve the immune system mistakenly attacking the artery walls. Several genetic and environmental factors may increase a person’s risk to develop giant cell arteritis.

4. Risk Factors

This is not an exhaustive list, and, as detailed above, exact causes have not been fully established. These factors could increase the likelihood of someone developing giant cell arteritis. It does not mean everyone with these risk factors will develop symptoms.

  • Prior history of cardiovascular disease has been linked. (10)
  • Associated with genetic variations in certain genes. (11)
  • 2-3 times more common in women. (12)

5. Prevalence

In the UK, the incidence of giant cell arteritis is less than 1% and the highest incidence is in women aged 70–79 years. (12)

6. Assessment & Diagnosis

A blood test can detect if there is inflammation in your body by picking up on certain markers in the blood. If the blood test shows a high level of inflammation and you have the symptoms, then giant cell arteritis might be a cause of your symptoms. However, the blood test is not 100% specific for identifying giant cell arteritis as other inflammatory conditions will also have the raised markers in blood associated with giant cell arteritis. Some people with giant cell arteritis have a normal blood test. (9)

To confirm the diagnosis a doctor may take a small part of the temporal artery (a biopsy) to look at under a microscope. If you have giant cell arteritis a doctor may be able to see inflammation and abnormal giant cells in the sample of the blood vessel (artery) wall. (3)

7. Self-Management

Once symptoms have improved and you have received treatment you can return to normal life following advice from your treating medical professional  Due to the time critical nature and risk of this condition, self management is not advised.

8. Rehabilitation

Most people with giant cell arteritis respond rapidly to treatment of certain steroids, such as prednisolone. However, relapses are common and occur in up to 50% of cases despite appropriate treatment. In general, treatment with steroids is usually needed for 1–2 years; in some cases, continued low dose prednisolone may be needed for several years. You may also be prescribed aspirin by your doctor, which helps reduce the risk of conditions like strokes and heart attacks.

9. Return to Sport / Normal life

Once symptoms have improved and you have received treatment you can return to normal life following advice from your treating medical professional.

Plantar Fasciitis

10. Other Treatment Options

The treatment options involve medical management and therefore urgent medical assessment from a doctor is recommended if any symptoms are experienced.

References

  1. Souza, A.W.S.D., Okamoto, K.Y.K., Abrantes, F., Schau, B., Bacchiega, A.B.S. & Shinjo, S.K. (2013). Giant cell arteritis: a multicenter observational study in Brazil. Clinics, 68(3), 317-322.
  2. Lazarewicz, K. & Watson, P. (2019). Giant cell arteritis. bmj, 365, 1964-1964.
  3. Schmidt, J. & Warrington, K.J. (2011). “Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients: Diagnosis and Pharmacological Management”, Drugs & aging, (28)8, 651-666.
  4. Suspecting giant cell arteritis | Diagnosis | Giant cell arteritis | CKS | NICE
  5. Singh, A.G., Kermani, T.A., Crowson, C.S., Weyand, C.M., Matteson, E.L. & Warrington, K.J. (2015). Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. The Journal of rheumatology, 42(2), 309-315.
  6. Winkler, A. & True, D. (2018). Giant cell arteritis: 2018 review. Missouri medicine, 115(5), 468.
  7. Peral-Cagigal, B., Pérez-Villar, Á., Redondo-González, L.M., García-Sierra, C., Morante-Silva, M., Madrigal-Rubiales, B. & Verrier-Hernández, A. (2018). Temporal headache and jaw claudication may be the key for the diagnosis of giant cell arteritis. Medicina oral, patologia oral y cirugia bucal, 23(3), 290.
  8. Evans, J.M. and Hunder, G.G. (2000). Polymyalgia rheumatica and giant cell arteritis. Rheumatic Disease Clinics of North America, 26(3), 493-515.
  9. Gonzalez‐Gay, M.A., Vazquez‐Rodriguez, T.R., Lopez‐Diaz, M.J., Miranda‐Filloy, J.A., Gonzalez‐Juanatey, C., Martin, J. & Llorca, J. (2009). Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Care & Research, 61(10), 1454-1461.
  10. Kobayashi, D., Suyama, Y., Osugi, Y., Arioka, H., Takahashi, O. & Kuriyama, N. (2018). Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study. International journal of rheumatic diseases, 21(6), 1314-1321.
  11. Carmona, F.D., Martín, J. & González-Gay, M.A. (2016). New insights into the pathogenesis of giant cell arteritis and hopes for the clinic. Expert review of clinical immunology, 12(1), 57-66.
  12. Yates, M., Graham, K., Watts, R.A. & MacGregor, A.J. (2016). The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population. BMC musculoskeletal disorders, 17(1), 1-9.

Other Conditions in Head, Neck, Neurological